Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.1007/s10654-021-00749-1 http://scihub22266oqcxt.onion/10.1007/s10654-021-00749-1 33884542!8059683!33884542     free     free     free Deprecated: Implicit conversion from float 231.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 231.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 231.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534       Eur+J+Epidemiol 2021 ; 36 (7): 727-734 Nephropedia Template TP {{tp|p=33884542|t=2021. Nationwide seroprevalence of antibodies against SARS-CoV-2 in Israel |pdf=|usr=}}{{33884542}} gab.com Text Nationwide seroprevalence of antibodies against SARS-CoV-2 in Israel JO: Eur J Epidemiol http://www.kidney.de/pget.php?&tw=1&pmid=33884542 #FOAvip The first local spread of COVID-19 in Israel was detected in March 2020. Due to the diversity in clinical presentations of COVID-19, diagnosis by RT-PCR alone might miss patients with mild or no symptoms. Serology testing may better evaluate the actual magnitude of the spread of infection in the population. This is the first nationwide seroprevalence study conducted in Israel. It is one of the most widespread to be conducted thus far, and the largest per-country population size. The survey was conducted between June 28 and September 14, 2020 and included 54,357 patients who arrived at the Health Maintenance Organizations to undergo a blood test for any reason. A patient was considered seropositive after two consecutive positive results with two different kits (Abbott and DiaSorin).The overall seroprevalence was 3.8% (95%CI 3.7-4.0), males higher than females [4.9% (95%CI 4.6-5.2) vs. 3.1% (95%CI 2.9-3.3) respectively]. Adolescents had the highest prevalence [7.8% (95%CI 7.0-8.6)] compared to other age groups. Participants who had undergone RT-PCR testing had a tenfold higher risk to be seropositive. The prevalence-to-incidence ratio was 4.5-15.7. Serology testing is an important complimentary tool for assessing the actual magnitude of infection and thus essential for implementing policy measures to control the pandemic. A positive serology test result was recently accepted in Israel as being sufficient to define recovery, with possible far-reaching consequences, such as the deploying of employees to ensure the maintenance of a functional economy. Twit Text FOAVip Nationwide seroprevalence of antibodies against SARS-CoV-2 in Israel ????Eur J Epidemiol http://www.kidney.de/pget.php?&tw=1&pmid=33884542 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=33884542 #FOAvip English Wikipedia <ref>{{Cite pmid|33884542}}</ref> Nationwide seroprevalence of antibodies against SARS-CoV-2 in Israel #MMPMID33884542 Reicher S; Ratzon R; Ben-Sahar S; Hermoni-Alon S; Mossinson D; Shenhar Y; Friger M; Lustig Y; Alroy-Preis S; Anis E; Sadetzki S; Kaliner E Eur J Epidemiol 2021[Jul]; 36 (7): 727-734 PMID33884542show ga The first local spread of COVID-19 in Israel was detected in March 2020. Due to the diversity in clinical presentations of COVID-19, diagnosis by RT-PCR alone might miss patients with mild or no symptoms. Serology testing may better evaluate the actual magnitude of the spread of infection in the population. This is the first nationwide seroprevalence study conducted in Israel. It is one of the most widespread to be conducted thus far, and the largest per-country population size. The survey was conducted between June 28 and September 14, 2020 and included 54,357 patients who arrived at the Health Maintenance Organizations to undergo a blood test for any reason. A patient was considered seropositive after two consecutive positive results with two different kits (Abbott and DiaSorin).The overall seroprevalence was 3.8% (95%CI 3.7-4.0), males higher than females [4.9% (95%CI 4.6-5.2) vs. 3.1% (95%CI 2.9-3.3) respectively]. Adolescents had the highest prevalence [7.8% (95%CI 7.0-8.6)] compared to other age groups. Participants who had undergone RT-PCR testing had a tenfold higher risk to be seropositive. The prevalence-to-incidence ratio was 4.5-15.7. Serology testing is an important complimentary tool for assessing the actual magnitude of infection and thus essential for implementing policy measures to control the pandemic. A positive serology test result was recently accepted in Israel as being sufficient to define recovery, with possible far-reaching consequences, such as the deploying of employees to ensure the maintenance of a functional economy. |*COVID-19 Serological Testing/methods[MESH] |Adolescent[MESH] |Adult[MESH] |Aged[MESH] |Aged, 80 and over[MESH] |Antibodies, Viral/*blood[MESH] |Biomarkers/blood[MESH] |COVID-19 Nucleic Acid Testing[MESH] |COVID-19/diagnosis/*epidemiology/virology[MESH] |Child[MESH] |Child, Preschool[MESH] |Female[MESH] |Humans[MESH] |Incidence[MESH] |Infant[MESH] |Infant, Newborn[MESH] |Israel/epidemiology[MESH] |Male[MESH] |Middle Aged[MESH] |Prevalence[MESH] |SARS-CoV-2/*immunology[MESH] |Seroepidemiologic Studies[MESH]Nationwide seroprevalence of antibodies against SARS-CoV-2 in Israel (epmc).pdf DeepDyve Pubget Overpricing